In recent years a continuous stream of new information on clinical, pathological and immunological aspects of paraneoplastic neurological syndromes has been published. In this survey, we will discuss current opinions on the value of anti-neuronal antibody detection for establishing a diagnosis of one of the paraneoplastic syndromes of the central nervous system.

, , , ,
This publication was made possible by Serono, Sanofi Winthrop, Yamanouchi, Amersham, GlaxoWelcome, Eli Lilly, Vital Aire, Bio-Rad, ITK/DAKO, Pharmaciai/Upjohm en het Nederlands Instituut voor Wetenschappelijk onderzoek
F.G.A. van der Meché (Frans)
Erasmus University Rotterdam
hdl.handle.net/1765/22521
Erasmus MC: University Medical Center Rotterdam

Moll, W. (1996, June 19). Paraneoplastic Syndromes of the Central Nervous System. Retrieved from http://hdl.handle.net/1765/22521